PharmaFluidics is a microfluidics company founded in 2012 and offers integrated milli- to nano-solutions for mixing, reaction and separation, with a focus on pharmaceutical processes and specialty chemistry. It is the aim of PharmaFluidics to facilitate the adoption of microfluidics in biotechnological and pharmaceutical processes. The company offers tailored solutions for processes that benefit from its unique expertise in micro- and nano-structured devices for the control of laminar flows, in a technology-independent fashion.
PharmaFluidics BVBA was founded in 2011 as a spin-off of the Department of Chemical Engineering (CHIS) at the VUB by Dr. ir. Wim De Malsche, Prof. Dr. ir. Gert Desmet, Prof. Dr. ir. Joeri Denayer and Dr. ir. Paul Jacobs. The company represents a unique combination of know-how, and has access to state-of-the-art clean rooms and micromachining capabilities that enable it to provide its clients with innovative products and novel concepts. During the last decade, the department of Chemical Engineering has played a pioneering role in the development of miniaturized devices for analytical and general chemical engineering applications.
PharmaFluidics became part of Thermo Fisher Scientific in November 2021.
Contact
PharmaFluidics
acquired by Thermo Fischer Scientific
Guldensporenpark 26
B-9820 Merelbeke
Belgium

MILESTONES
- 2011: PharmaFluidics established
- 2012: first contract development agreement with large pharma company
- 2013: demonstration of sub-micron plate heights implementing a novel support structure format for HPLC
- 2013: development of generic ultra-stable membrane contactor
- 2017: µPAC™ honoured in The Analytical Scientist Innovation Awards 2017
- 2018: PharmaFluidics raises 7.3 million euro
- 2019: introduction µPAC™ trapping column
- 2020: receives VLAIO grant of €613.000
- 2021: acquired by Thermo Fisher Scientific